Difference between revisions of "Metastases"
Jump to navigation
Jump to search
m (→Pending) |
m (→Pending: fix typo) |
||
| Line 68: | Line 68: | ||
NEGATIVE: CK20, TTF-1, CDX2, HER2, GCDFP. | NEGATIVE: CK20, TTF-1, CDX2, HER2, GCDFP. | ||
The immunostaining | The immunostaining profile is compatible with a metastatic breast carcinoma. | ||
ER, PR and HER2 are interpreted as Class I IHC tests (results used by pathologists), | ER, PR and HER2 are interpreted as Class I IHC tests (results used by pathologists), | ||